2型糖尿病诊断年龄对死亡率和血管并发症的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入26项观察性研究、共1,325,493名来自30个国家的成人2型糖尿病患者,评估诊断年龄与死亡、大血管及微血管并发症的关联。结果显示,诊断年龄每增加1岁(校正当前年龄后),全因死亡、大血管疾病和微血管疾病风险分别降低4%、3%和5%(均p<0.001)。结论提示较年轻诊断2型糖尿病与更高的死亡和血管疾病风险相关。
要点
- 诊断年龄每增1岁,全因死亡风险降4%(校正当前年龄后)
- 诊断年龄每增1岁,大血管疾病风险降3%
- 诊断年龄每增1岁,微血管疾病风险降5%
核心结论
- 较年轻而非较年长的2型糖尿病诊断年龄与更高的死亡率和血管疾病风险相关。
- 早期且持续的干预以延迟2型糖尿病发病并改善已诊断患者的血糖和心血管风险特征,对降低发病率和死亡率至关重要。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和All EBM数据库自建库至2018年7月。
- 纳入26项观察性研究,共1,325,493名来自30个国家的成人2型糖尿病患者。
- 采用随机效应荟萃分析及逆方差加权获得合并OR值,研究方案注册于PROSPERO(CRD42016043593)。
主要发现
- 诊断年龄与全因死亡、大血管疾病和微血管疾病风险均呈负相关(均p<0.001)。
- 校正当前年龄后,诊断年龄每增加1年,全因死亡风险降低4%。
- 校正当前年龄后,诊断年龄每增加1年,大血管疾病风险降低3%。
- 校正当前年龄后,诊断年龄每增加1年,微血管疾病风险降低5%。
- 复合结局各组分的效果一致(均p<0.001)。
临床怎么用
- 对较年轻诊断2型糖尿病的患者应重视早期且持续的干预,以改善血糖和心血管风险特征。
- 延迟2型糖尿病发病可能有助于降低死亡和血管并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Few studies examine the association between age at diagnosis and subsequent complications from type 2 diabetes. This paper aims to summarise the risk of mortality, macrovascular complications and microvascular complications associated with age at diagnosis of type 2 diabetes. METHODS: Data were sourced from MEDLINE and All EBM (Evidence Based Medicine) databases from inception to July 2018. Observational studies, investigating the effect of age at diabetes diagnosis on macrovascular and microvascular diabetes complications in adults with type 2 diabetes were selected according to pre-specified criteria. Two investigators independently extracted data and evaluated all studies. If data were not reported in a comparable format, data were obtained from authors, presented as minimally adjusted ORs (and 95% CIs) per 1 year increase in age at diabetes diagnosis, adjusted for current age for each outcome of interest. The study protocol was recorded with PROSPERO International Prospective Register of Systematic Reviews (CRD42016043593). RESULTS: Data from 26 observational studies comprising 1,325,493 individuals from 30 countries were included. Random-effects meta-analyses with inverse variance weighting were used to obtain the pooled ORs. Age at diabetes diagnosis was inversely associated with risk of all-cause mortality and macrovascular and microvascular disease (all p < 0.001). Each 1 year increase in age at diabetes diagnosis was associated with a 4%, 3% and 5% decreased risk of all-cause mortality, macrovascular disease and microvascular disease, respectively, adjusted for current age. The effects were consistent for the individual components of the composite outcomes (all p < 0.001). CONCLUSIONS/INTERPRETATION: Younger, rather than older, age at diabetes diagnosis was associated with higher risk of mortality and vascular disease. Early and sustained interventions to delay type 2 diabetes onset and improve blood glucose levels and cardiovascular risk profiles of those already diagnosed are essential to reduce morbidity and mortality. Graphical abstract.
引用
- Nanayakkara N, Curtis AJ, Heritier S, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2020. PMID: 33313987. doi:10.1007/s00125-020-05319-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。